查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1994242

主動脈修復器材市場：按類型、材料、最終用戶和應用分類 - 2026-2032年全球市場預測

Aortic Repair Device Market by Type, Material, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年主動脈修復器材市場價值為 33.2 億美元，預計到 2032 年將達到 62.1 億美元，2026 年複合年成長率為 9.32%，達到 36 億美元。

主要市場統計數據
基準年 2025 33.2億美元
預計年份：2026年 36億美元
預測年份 2032 62.1億美元
複合年成長率 (%) 9.32%

全面概述了影響主動脈修復裝置開發和商業性部署的臨床因素、技術應對措施和醫療保健系統優先事項。

主動脈修復器材領域已發展成為一個多學科交叉的領域，臨床需求、技術進步和醫療保健系統優先事項在此交匯融合。近年來，臨床醫生越來越傾向於在適當情況下採用微創方法，而器械設計者則透過模組化、改進輸送系統以及增強與影像診斷的兼容性來應對這一趨勢。同時，採購和政策制定機構更加重視器械的耐用性、治療總成本以及上市後安全性監測。因此，器械開發人員必須成功應對臨床證據要求、材料科學限制和手術流程等複雜因素，才能在不同的治療環境中獲得應用。本文概述了影響器材設計和部署的核心技術和臨床因素，強調了器材功能與臨床醫生工作流程相匹配的重要性，並闡述了影響策略決策的商業性和監管考量。評估醫療設備商業機會的相關人員不僅應考慮手術性能，還應考慮供應鏈的韌性、服務和培訓模式以及不斷變化的支付方和醫療保健系統期望。這是因為這些廣泛的因素正日益決定長期的商業性可行性和推廣動能。

臨床創新、監管進步和採購變革如何共同加速整個主動脈修復設備生態系統中整合產品和服務模式的發展。

一場意義深遠的變革浪潮正在重塑主動脈修復器械的研發、生產和應用方式。血管內輸送系統和影像整​​合技術的進步，使得針對更複雜解剖結構的微創治療成為可能，從而為以往只能接受開胸手術的患者群體拓展了治療選擇。同時，材料科學的進步和器械設計的迭代改進，提升了器械的耐用性和解剖結構匹配度，促使人們重新評估追蹤通訊協定和二次干預的閾值。在商業層面，基於價值的採購和基於結果的合約要求供應商不僅要證明手術成功，還要證明長期患者療效和經濟合理性。此外，全球監管機構都在強調真實世界數據（REW）和上市後監測的重要性，敦促製造商投資於註冊登記基礎設施和遠端監測能力。供應鏈整合、原始設備製造商（OEM）與專業製造商之間的策略合作，以及對本地生產能力的日益重視，都是應對地緣政治和宏觀經濟壓力的新措施。總而言之，該領域正在朝著更一體化的產品和服務提案轉變，將臨床表現、生命週期管理和實證價值交付相結合。

評估累積關稅措施對醫療設備採購和製造經濟造成的多方面供應鏈、採購和營運影響。

美國近期實施的關稅措施的累積影響波及整個主動脈修復器械供應鏈，並波及籌資策略和採購決策。對中間組件和成品徵收的進口關稅推高了依賴全球化供應鏈的製造商的收貨成本，促使他們重新評估供應商組成和合約條款。為應對這項挑戰，各公司正在尋求多元化採購管道，以減少對特定貿易路線的依賴，擴大紡織移植物材料和輸送系統組件等關鍵投入品的雙重採購，並在經濟和物流可行的生產階段加快本地化進程。醫療機構和集團採購組織則透過仔細審查總擁有成本，並尋求能夠透過批量折扣和風險分擔協議來緩解暫時成本壓力的長期合約來應對。與監管合規和關稅相關的海關程序日益複雜，也增加了製造商和經銷商的管理成本，延長了前置作業時間，並使庫存計劃更加複雜。總體而言，關稅環境正在推動戰略韌性措施，例如庫存最佳化、供應商冗餘以及臨床、採購和製造部門之間的密切合作，同時進一步加強最佳化成本，而不損害臨床表現或患者安全。

透過綜合細分分析，揭示醫療設備類型、臨床應用、醫療環境和植入材料如何共同決定臨床效用和市場定位。

細分市場層面的趨勢揭示了器材設計選擇、臨床適應症、治療環境和材料選擇如何相互交織，並塑造其應用路徑和競爭優勢。按類型分類，器械可分為「血管內血管支架」和「開放性手術移植物」。在血管內血管支架類別中，產品系列分別對應於「單主動脈-單髂動脈」解剖結構、「分叉」解剖結構和「袖套」配置，每種結構都帶來獨特的設計和輸送挑戰，從而影響醫生的偏好和庫存策略。按適應症分類，臨床需求涵蓋腹部主動脈血管瘤的治療、主動脈夾層的管理以及胸主動脈瘤的介入治療，而解剖結構的複雜性和手術全期風險狀況決定了器械的選擇和所需的手術支持。根據最終用戶的不同，植入環境涵蓋門診手術中心、醫院手術室和混合手術室等，手術能力、報銷機制和配套基礎設施決定了特定類型器械在哪些場所最為有效。根據材料的不同，主要的移植物性質，例如聚酯和聚四氟乙烯，各自具有不同的編織方式、密封性能和組織整合特性，這些都會影響器械的操作、長期耐用性以及滅菌和儲存物流。透過整合這些細分層面，策略規劃者可以確定分階段設計創新、針對性臨床證據或供應鏈調整將在哪些方面產生最顯著的商業性和臨床影響。

一項區域比較分析，詳細說明了醫療保健基礎設施、報銷框架和當地製造業優先事項如何影響採用和商業化路徑。

區域趨勢影響著整個主動脈修復器材市場的競爭機會和業務重點，不同地區的需求推動要素和醫療保健系統結構各不相同。在美洲，高手術量、先進的影像基礎設施以及醫療中心集中的血管外科專家支持複雜血管內解決方案的快速普及。同時，支付方趨勢和醫院採購流程強調已證實的長期療效和成本效益。歐洲、中東和非洲（EMEA）市場環境複雜多樣，監管協調、區域報銷方案差異以及不斷變化的醫院容量都會影響部署進度。在一些市場，集中高效的醫療中心推動了器械的部署，而在其他市場，有限的資源則優先考慮較簡單的介入治療。亞太地區醫療保健成熟度差異顯著，患者群體龐大，對微創技術的投資不斷增加，並且越來越重視本土製造和技術轉移。在每個地區，臨床培訓項目、上市後註冊登記的策略性本地化以及與目標分銷商的合作都能加速器械的普及並減少物流障礙。同時，制定持續的證據產生計劃並根據當地採購標準定製經營模式，對於永續的市場滲透至關重要。

對競爭格局進行了細緻的概述，重點介紹了成熟公司的產品系列、專業創新者和合作夥伴關係如何塑造差異化和長期商業性韌性。

競爭動態由成熟的醫療設備製造商、專業的血管技術公司以及專注於輸送系統、移植物材料和影像整合的敏捷創新者共同塑造。成熟企業優先考慮產品組合的廣度、經證實的長期療效以及全球分銷網路，從而能夠為不同的醫院系統提供產品並支援大規模臨床註冊研究。專業企業和新參與企業則透過專注於特定領域的創新來脫穎而出，例如低輪廓輸送導管、模組化移植物結構以及針對複雜解剖結構量身定做的先進密封技術。材料科學家、組件供應商和臨床研究機構 (CRO) 之間的跨領域夥伴關係加速了迭代周期，縮短了從概念到概念驗證的時間。同時，諸如附加收購、共同開發契約和獨家分銷協議等策略活動是進入細分臨床領域和獲取互補技術堆疊的常用策略。對於買家和潛在合作夥伴而言，評估合作夥伴的持續臨床支援能力、上市後證據產生能力和物流可靠性與評估單一設備功能的新穎性同等重要。同樣，能夠靈活應對監管要求，並在多學科醫院環境中擁有良好的業績記錄，通常是區分長期贏家和臨時進入者的因素。

醫療設備製造商和醫療保健相關人員將技術創新轉化為永續臨床應用和穩健商業性表現的行動導向策略重點

產業領導者應推動一系列合作舉措，以協調臨床效用、業務韌性和支付方的期望。首先，應優先產生可靠的臨床證據，並投資於上市後監測，以證明長期療效並支持基於價值的合約談判。其次，應加快工程研發，以降低手術複雜性並擴大解剖學適用範圍，從而擴大目標臨床醫生群體，並促進在資源受限環境中的部署。同時，應透過雙重採購、關鍵部件的本地化生產以及加強與主要分銷商的需求資訊共用來提高供應鏈柔軟性，從而減輕關稅和物流中斷的影響。此外，應透過整合培訓和手術支援服務來強化經營模式，以縮短複雜手術的學習曲線，並調整定價和合約方式以反映醫療保健的總成本。最後，應確保在整合計畫中保持臨床重點和監管合規性，同時尋求策略夥伴關係和有針對性的併購，以獲取利基能力、擴展服務組合或進入新的地域管道。這些合作措施將使各組織能夠把技術創新轉化為永續的臨床部署和永續的商業性績效。

我們嚴謹的混合方法研究框架，結合了對從業者的訪談、技術文獻的回顧和交叉檢驗，產生了可操作的、有臨床支持的見解。

本研究系統地整合了與關鍵相關人員的溝通、對二手文獻的回顧以及跨部門檢驗，以確保研究結果基於證據、具有可操作性並反映當前市場實際情況。主要資訊來源包括對血管外科醫生、採購負責人、生物醫學工程師和監管專家的訪談，旨在從醫療專業人員的觀點了解醫療設備的性能、手術流程的限制以及採購標準。二手資訊來源包括同行評審的臨床文獻、監管指導文件和製造商的技術文檔，以支援器械特性和證據標準。分析方法優先採用三角驗證法，交叉檢驗臨床發現、技術規格和採購實踐，以減少偏差並突出一致的模式。必要時，應用敏感度分析來解釋醫院能力和報銷模式的區域差異。本研究也納入了供應鏈映射和情境分析，以識別結構性脆弱性和可行的緩解策略。最後，研究結果經過臨床和行業專家的同行評審，以完善結論和建議，確保其對商業、臨床和政策等各職能部門的決策者都具有可操作性。

一份綜合總結，重點闡述臨床創新、證據產生和營運韌性如何決定長期應用和系統性價值獲取。

總而言之，主動脈修復器材產業正處於一個轉折點，其戰略重點正透過臨床創新、監管機構對真實世界數據（REW）的重視以及採購對可驗證價值的需求等因素的綜合作用而不斷調整。血管內輸送、移植物材料和影像整合的技術進步拓展了治療選擇，並提高了複雜解剖結構手術的可行性。同時，企業需要採取積極的應對措施，以應對關稅、供應鏈波動和區域採購標準帶來的營運壓力。那些能夠使產品設計與臨床醫生工作流程相契合、投資於長期循證研究並採用靈活的生產和商業模式的公司，最有可能實現永續的市場推廣。同樣重要的是，企業還需最佳化區域打入市場策略、建構培訓生態系統，並建立能夠加速實證研究和提升物流可靠性的夥伴關係。臨床表現、服務導向商業模式和穩健的價值鏈的結合，將是決定哪些企業能夠贏得長期臨床信任和系統性價值的關鍵因素。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：主動脈修復器材市場：按類型分類

  • 血管內支架血管支架
    • 主動脈和單側髂骨
    • 分支類型
    • 袖口
  • 用於開放性手術的移植

第9章：主動脈修復器材市場：依材料分類

  • 聚酯纖維
  • PTFE

第10章：主動脈修復器材市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第11章 主動脈修復器材市場：依應用領域分類

  • 腹部主動脈血管瘤
  • 主動脈剝離
  • 胸主動脈瘤

第12章 主動脈修復器材市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 主動脈修復器材市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 主動脈修復器材市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國主動脈修復器材市場

第16章：中國主動脈修復器材市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Artivion Inc
  • Becton Dickinson and Company
  • Bentley InnoMed GmbH
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • Cardinal Health Inc
  • Cook Group Incorporated
  • CryoLife Inc
  • Edwards Lifesciences Corporation
  • Endologix LLC
  • Getinge AB
  • Johnson & Johnson
  • JOTEC GmbH
  • LeMaitre Vascular Inc
  • Lombard Medical Technologies plc
  • Medtronic plc
  • Merit Medical Systems Inc
  • MicroPort Scientific Corporation
  • Penumbra Inc
  • Shanghai MicroPort Endovascular MedTech Co., Ltd
  • Straub Medical AG
  • Stryker Corporation
  • Terumo Corporation
  • WL Gore & Associates Inc
Product Code: MRR-1A1A064C04D2

The Aortic Repair Device Market was valued at USD 3.32 billion in 2025 and is projected to grow to USD 3.60 billion in 2026, with a CAGR of 9.32%, reaching USD 6.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.32 billion
Estimated Year [2026] USD 3.60 billion
Forecast Year [2032] USD 6.21 billion
CAGR (%) 9.32%

A comprehensive contextual overview of clinical drivers, engineering responses, and health system priorities that are reshaping aortic repair device development and commercial adoption

The aortic repair device landscape has matured into a multidisciplinary domain where clinical needs, engineering advances, and health system priorities intersect. Over recent years, clinicians have increasingly favored less invasive approaches where appropriate, while device designers have responded with modularity, improved delivery systems, and enhanced imaging compatibility. At the same time, procurement and policy bodies have placed greater emphasis on device durability, total cost of care, and post-market safety surveillance. Consequently, device developers must navigate a complex matrix of clinical evidence requirements, material science constraints, and procedural workflows to achieve adoption across diverse treatment settings. This introduction outlines the core technological and clinical drivers shaping device design and deployment, emphasizes the importance of alignment between device capabilities and clinician workflow, and frames the commercial and regulatory considerations that influence strategic decisions. Stakeholders evaluating device opportunities should consider not only procedural performance but also supply chain resilience, service and training models, and the evolving expectations of payers and health systems, since these broader factors increasingly determine long-term commercial viability and adoption momentum.

How clinical innovation, regulatory evolution, and procurement transformation are jointly accelerating integrated product and service models across aortic repair device ecosystems

Significant transformative shifts are redefining where and how aortic repair devices are developed, manufactured, and used. Advances in endovascular delivery systems and imaging integration have enabled more complex anatomies to be treated less invasively, expanding therapeutic options for patient cohorts previously limited to open surgery. Concurrently, material science improvements and iterative device design have increased device longevity and anatomical compatibility, prompting a reassessment of follow-up protocols and secondary intervention thresholds. On the commercial side, value-based procurement and outcomes-linked contracting have pressured suppliers to demonstrate not just procedure success but longitudinal patient outcomes and economic rationale. In parallel, regulatory agencies worldwide are emphasizing real-world evidence and post-market surveillance, which is encouraging manufacturers to invest in registry infrastructure and remote monitoring capabilities. Supply chain consolidation, strategic partnerships between OEMs and specialty manufacturers, and an increased focus on localized manufacturing capacity are all emergent responses to geopolitical and macroeconomic pressures. Taken together, these shifts are moving the sector toward more integrated product-service propositions that combine clinical performance with lifecycle management and evidence-based value delivery.

Assessing the multifaceted supply chain, procurement, and operational consequences resulting from cumulative tariff actions that have affected medical device sourcing and manufacturing economics

The cumulative impact of recent tariff measures implemented in the United States has reverberated across supply chains, procurement strategies, and sourcing decisions for aortic repair devices. Import duties on intermediate components and finished devices have raised landed costs for manufacturers reliant on globalized supply chains, prompting a reassessment of supplier mixes and contract terms. In response, companies have diversified procurement to reduce exposure to specific trade routes, expanded dual-sourcing arrangements for critical inputs such as textile graft materials and delivery-system components, and accelerated plans to localize certain production stages where economically and logistically feasible. Health systems and group purchasing organizations have reacted by scrutinizing total cost of ownership and by seeking longer-term agreements that can absorb episodic cost pressures through volume rebates or risk-sharing arrangements. Regulatory compliance and tariff-related customs complexities have also increased administrative overhead for manufacturers and distributors, lengthening lead times and complicating inventory planning. Overall, the tariff environment has incentivized strategic resilience measures-inventory optimization, supplier redundancy, and closer collaboration between clinical, procurement, and manufacturing functions-while also sharpening the focus on cost optimization initiatives that do not compromise clinical performance and patient safety.

Integrated segmentation analysis revealing how device type, clinical application, care setting, and graft material collectively determine clinical utility and commercial positioning

Segment-level dynamics reveal how device design choices, clinical indications, treatment settings, and material selection intersect to shape adoption pathways and competitive differentiation. Based on Type, devices are categorized into Endovascular Stent Graft and Open Surgical Graft; within the Endovascular Stent Graft category, product families address Aortomonoiliac geometries, Bifurcated anatomies, and Cuff configurations, each presenting distinct engineering and delivery challenges that influence physician preference and inventory strategies. Based on Application, clinical demand arises across Abdominal Aortic Aneurysm treatment, management of Aortic Dissection, and interventions for Thoracic Aortic Aneurysm, with anatomical complexity and perioperative risk profiles guiding device selection and required procedural support. Based on End User, delivery settings range from Ambulatory Surgical Center environments to Hospital-based operating rooms and hybrid suites, with procedural throughput, reimbursement structures, and support infrastructure informing where specific device types are most viable. Based on Material, core graft substrates such as Dacron and PTFE offer different weaving, sealing, and tissue-integration properties, which in turn affect device handling, long-term durability considerations, and sterilization or storage logistics. By synthesizing these segmentation layers, strategic planners can identify where incremental design innovations, targeted clinical evidence, or supply-chain adjustments will have the most pronounced commercial and clinical impact.

Comparative regional analysis detailing how healthcare infrastructure, reimbursement frameworks, and local manufacturing priorities influence adoption and commercialization pathways

Regional dynamics shape competitive opportunity and operational priorities across the aortic repair device landscape, with demand drivers and health system structures varying by geography. In the Americas, high procedure volumes, advanced imaging infrastructure, and concentrated centers of vascular expertise support rapid adoption of complex endovascular solutions, while payer dynamics and hospital procurement processes place a premium on demonstrable long-term outcomes and cost-effectiveness. Europe, Middle East & Africa presents a heterogeneous environment where regulatory harmonization, regional reimbursement variances, and evolving hospital capacity influence adoption timelines; in some markets centralized centers of excellence facilitate uptake, whereas in others constrained resources prioritize simpler interventions. Asia-Pacific encompasses a broad spectrum of healthcare maturity, with large treatment populations, increasing investment in minimally invasive capabilities, and a growing emphasis on domestic manufacturing and technology transfer. Across regions, strategic localization of clinical training programs, post-market registries, and targeted distributor partnerships can accelerate adoption and mitigate logistical barriers, while aligned evidence-generation plans and customization of commercial models to regional procurement norms will be decisive for sustained market penetration.

A nuanced competitive snapshot highlighting how incumbent portfolios, focused innovators, and collaborative partnerships are shaping differentiation and long-term commercial resilience

Competitive dynamics are shaped by a blend of incumbent device manufacturers, specialized vascular technology firms, and agile innovators focusing on delivery systems, graft materials, and imaging integration. Established players emphasize portfolio breadth, demonstrated long-term outcomes, and global distribution networks, which enable them to supply diverse hospital systems and support large-scale clinical registries. Specialized firms and newer entrants are differentiating through focused innovations such as lower-profile delivery catheters, modular graft architectures, and enhanced sealing technologies tailored to challenging anatomies. Cross-sector partnerships between material scientists, component suppliers, and clinical research organizations are accelerating iteration cycles while reducing time-to-proof-of-concept. Meanwhile, strategic activities including bolt-on acquisitions, co-development agreements, and exclusive distribution arrangements are common tactics to access niche clinical segments or complementary technology stacks. For purchasers and potential collaborators, evaluating a partner's capacity for sustained clinical support, post-market evidence generation, and logistical reliability is as important as assessing the novelty of a single device feature. Equally, agility in addressing regulatory requirements and demonstrated success in multidisciplinary hospital environments often distinguishes long-term winners from transient entrants.

Action-oriented strategic priorities for device makers and healthcare stakeholders to convert technical innovation into durable clinical adoption and resilient commercial performance

Industry leaders should pursue a coordinated set of actions that align clinical utility with operational resilience and payer expectations. First, prioritize investment in robust clinical evidence generation and post-market surveillance to substantiate long-term outcomes and to support value-based contracting conversations. Next, accelerate engineering efforts that reduce procedural complexity and broaden anatomical applicability, thereby increasing the addressable clinician base and facilitating adoption in lower-resource settings. Simultaneously, enhance supply chain flexibility through dual sourcing, localized production of critical components, and improved demand signal sharing with key distributors to mitigate tariff and logistics shocks. Strengthen commercial models by integrating training and procedural support offerings to reduce the learning curve for complex interventions, and tailor pricing and contracting approaches to reflect total cost of care rather than device price alone. Finally, pursue strategic partnerships and targeted M&A to acquire niche capabilities, expand service portfolios, or access new geographic channels, while ensuring that integration plans preserve clinical focus and regulatory compliance. These coordinated actions will enable organizations to translate technical innovation into durable clinical adoption and sustainable commercial performance.

A rigorous mixed-methods research framework combining practitioner interviews, technical literature review, and cross-validation to produce actionable and clinically grounded insights

This research synthesis draws on a structured combination of primary stakeholder engagement, secondary literature review, and cross-functional validation to ensure findings are grounded, actionable, and reflective of current market realities. Primary inputs included interviews with vascular surgeons, purchasing managers, biomedical engineers, and regulatory specialists to capture practitioner perspectives on device performance, procedural workflow constraints, and procurement criteria. Secondary sources encompassed peer-reviewed clinical literature, regulatory guidance documents, and manufacturer technical files to corroborate device characteristics and evidence standards. The analytical approach prioritized triangulation, whereby clinical insights, technical specifications, and procurement practices were cross-validated to reduce bias and highlight consistent patterns. Where appropriate, sensitivity checks were applied to account for regional variability in hospital capabilities and reimbursement models. The research also incorporated supply chain mapping and scenario analysis to identify structural vulnerabilities and practical mitigation strategies. Finally, findings were peer-reviewed by clinical and industry experts to refine conclusions and ensure that recommendations are practical for decision-makers across commercial, clinical, and policy functions.

Convergent summary highlighting how clinical innovation, evidence generation, and operational resilience determine long-term adoption and systemic value capture

In sum, the aortic repair device sector is at an inflection point where clinical innovation, regulatory emphasis on real-world evidence, and procurement demands for demonstrable value are jointly shaping strategic priorities. Technological progress in endovascular delivery, graft materials, and imaging integration has expanded therapeutic options and improved procedural feasibility for complex anatomies, while operational pressures from tariffs, supply chain volatility, and regional procurement norms require proactive resilience measures. Companies that align product design with clinician workflow, invest in longitudinal evidence, and adopt flexible manufacturing and commercial models are best positioned to achieve sustained adoption. Equally important is the ability to tailor regional go-to-market strategies, cultivate training ecosystems, and form partnerships that accelerate evidence generation and logistical reliability. The combination of clinical performance, service-oriented commercial models, and supply-chain robustness will be decisive in determining which organizations capture long-term clinical trust and system-level value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Aortic Repair Device Market, by Type

  • 8.1. Endovascular Stent Graft
    • 8.1.1. Aortomonoiliac
    • 8.1.2. Bifurcated
    • 8.1.3. Cuff
  • 8.2. Open Surgical Graft

9. Aortic Repair Device Market, by Material

  • 9.1. Dacron
  • 9.2. PTFE

10. Aortic Repair Device Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Hospital

11. Aortic Repair Device Market, by Application

  • 11.1. Abdominal Aortic Aneurysm
  • 11.2. Aortic Dissection
  • 11.3. Thoracic Aortic Aneurysm

12. Aortic Repair Device Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Aortic Repair Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Aortic Repair Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Aortic Repair Device Market

16. China Aortic Repair Device Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Artivion Inc
  • 17.7. Becton Dickinson and Company
  • 17.8. Bentley InnoMed GmbH
  • 17.9. Biotronik SE & Co KG
  • 17.10. Boston Scientific Corporation
  • 17.11. Cardinal Health Inc
  • 17.12. Cook Group Incorporated
  • 17.13. CryoLife Inc
  • 17.14. Edwards Lifesciences Corporation
  • 17.15. Endologix LLC
  • 17.16. Getinge AB
  • 17.17. Johnson & Johnson
  • 17.18. JOTEC GmbH
  • 17.19. LeMaitre Vascular Inc
  • 17.20. Lombard Medical Technologies plc
  • 17.21. Medtronic plc
  • 17.22. Merit Medical Systems Inc
  • 17.23. MicroPort Scientific Corporation
  • 17.24. Penumbra Inc
  • 17.25. Shanghai MicroPort Endovascular MedTech Co., Ltd
  • 17.26. Straub Medical AG
  • 17.27. Stryker Corporation
  • 17.28. Terumo Corporation
  • 17.29. W. L. Gore & Associates Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AORTIC REPAIR DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AORTIC REPAIR DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES AORTIC REPAIR DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA AORTIC REPAIR DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY AORTOMONOILIAC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY AORTOMONOILIAC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY AORTOMONOILIAC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY BIFURCATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY BIFURCATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY BIFURCATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY CUFF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY CUFF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY CUFF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY OPEN SURGICAL GRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY OPEN SURGICAL GRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY OPEN SURGICAL GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY DACRON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY DACRON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY DACRON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY PTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY PTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY PTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY AORTIC DISSECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY AORTIC DISSECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY AORTIC DISSECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS AORTIC REPAIR DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 45. AMERICAS AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. NORTH AMERICA AORTIC REPAIR DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA AORTIC REPAIR DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. LATIN AMERICA AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA AORTIC REPAIR DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE AORTIC REPAIR DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST AORTIC REPAIR DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA AORTIC REPAIR DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC AORTIC REPAIR DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN AORTIC REPAIR DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. GCC AORTIC REPAIR DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GCC AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. GCC AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 102. GCC AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. GCC AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. GCC AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION AORTIC REPAIR DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS AORTIC REPAIR DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. BRICS AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. G7 AORTIC REPAIR DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. G7 AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. G7 AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 120. G7 AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. G7 AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. G7 AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. NATO AORTIC REPAIR DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NATO AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NATO AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 126. NATO AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. NATO AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. NATO AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL AORTIC REPAIR DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES AORTIC REPAIR DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA AORTIC REPAIR DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. CHINA AORTIC REPAIR DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA AORTIC REPAIR DEVICE MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA AORTIC REPAIR DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA AORTIC REPAIR DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA AORTIC REPAIR DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)